Diabetes treatment is constantly advancing, with new therapeutic options developing to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic https://kathrynfwta417848.vigilwiki.com/7437230/promising_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment